|Original language||English (US)|
|Number of pages||2|
|Journal||Diagnostic Microbiology and Infectious Disease|
|State||Published - Feb 2011|
Bibliographical noteFunding Information:
We thank Dr. David Landman and Dr. John Quale (SUNY Downstate Medical Center, Brooklyn, NY) for providing the clinical isolate (VM9) used as positive control. There was no financial support for the study. V.H.T. has received unrestricted research funding from AstraZeneca, Merck, Achaogen, and is on the speaker's bureau of Merck.